These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5810198)

  • 1. Potential anticancer agents. V. The synthesis and biochemical studies of 5-fluorinated pyrimidine-6-carboxaldehydes and derivatives.
    Piantadosi C; Kim CS; Irvin JL
    J Pharm Sci; 1969 Jul; 58(7):821-6. PubMed ID: 5810198
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential anticancer agents. VI. 5-Substituted pyrimidine-6-carboxaldehydes.
    Hong CI; Piantadosi C; Irvin JL
    J Pharm Sci; 1970 Nov; 59(11):1637-45. PubMed ID: 5495493
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential anticancer agents. IV. 5-Substituted pyrimidine-6-carboxaldehydes and derivatives.
    Hong CI; Piantadosi C; Chae CB; Irvin JL
    J Med Chem; 1968 Nov; 11(6):1182-9. PubMed ID: 5680034
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential anticancer agents. 3. 2-Phthalimidoaldehydes and derivatives.
    Craig JB; Piantadosi C; Irvin JL; Cheng SS
    J Med Chem; 1967 Nov; 10(6):1071-3. PubMed ID: 6056033
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticancer effects of propanals: comparison between human and animal tumor systems.
    Apple MA; Cline MJ
    Natl Cancer Inst Monogr; 1971 Dec; 34():161-5. PubMed ID: 5140861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on pyrazolo [3,4-d] pyrimidine derivatives. VIII. On syntheses and anti-tumor activity of 4-amino-1-(o-, m- or p-nitrophenyl) -1H-pyrazolo[3,4-d] pyrimidines and their derivatives (author's transl)].
    Hayashi E; Higashino T; Suzuki S; Kato T; Kohno M; Shinoda H; Mizuno D
    Yakugaku Zasshi; 1977 Dec; 97(12):1328-33. PubMed ID: 609046
    [No Abstract]   [Full Text] [Related]  

  • 7. POTENTIAL ANTICANCER AGENTS. I. SCHIFF BASES AND HYDRAZONE DERIVATIVES OF PYRIMIDINE-4-CARBOXALDEHYDES.
    PIANTADOSI C; SKULASON VG; IRVIN JL; POWELL JM; HALL L
    J Med Chem; 1964 May; 7():337-42. PubMed ID: 14204971
    [No Abstract]   [Full Text] [Related]  

  • 8. Isothiazolopyrimidines--new group of anticancer agents. I.
    MachoĊ„ Z; Wieczorek J; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialdehyde derivative of 5'-deoxyinosine as a more potent analog of the dialdehyde derivative of inosine (NSC 118994).
    Cory JG; Parker SH
    Biochem Pharmacol; 1979 Mar; 28(6):867-71. PubMed ID: 454484
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of 4-aminopyrazolo(3,4-d)pyrimidine and guanine on Ehrlich ascites cells in culture.
    Schachtschabel DO; Ferro JJ
    Exp Cell Res; 1967 Nov; 48(2):319-26. PubMed ID: 6082315
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antineoplastic activity of preparations of the series of phenoxazine dyes].
    D'iachkovskaia RF; Parkhomenko II; Vasil'eva LS; Surkova NI; Shuppe NG; Konovalova NP; Bogdanov GN; Emanuel' NM
    Farmakol Toksikol; 1969; 32(1):84-7. PubMed ID: 5770324
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives.
    Nantka-Namirski P; Kaczmarek L
    Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor agents LII: The effects of molephantinin on nucleic acid and protein synthesis of Ehrlich ascites cells.
    Hall IH; Liou YF; Lee KH
    J Pharm Sci; 1982 Jun; 71(6):687-90. PubMed ID: 7097535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activity of the Ehrlich ascites carcinoma cells and the significance of ascites serum addition.
    Miko M; Drobnica L
    Neoplasma; 1969; 16(2):161-9. PubMed ID: 5822918
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor and antimitogenic properties of cis-dichloro(dipyridine)platinum(II).
    Gale GR; Howle JA; Walker EM
    Cancer Res; 1971 Jul; 31(7):950-2. PubMed ID: 4934676
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of energy metabolism in Ehrlich ascites cells treated with dactylarin in vitro.
    Miko M; Drobnica L; Chance B
    Cancer Res; 1979 Oct; 39(10):4242-51. PubMed ID: 476657
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibitory action of retinoic acid and N-(4-carboxyphenyl)-retinamide on the biosynthesis of DNA, RNA and protein in Ehrlich ascites carcinoma].
    Song ZP; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Dec; 6(6):418-20. PubMed ID: 6242543
    [No Abstract]   [Full Text] [Related]  

  • 18. Sesquiterpene antitumor agents: inhibitors of cellular metabolism.
    Lee KH; Hall IH; Mar EC; Starnes CO; ElGebaly SA; Waddell TG; HADGRAFT RI; Ruffner CG; Weidner I
    Science; 1977 Apr; 196(4289):533-6. PubMed ID: 191909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of certain new thiieno [2,3-d] pyrimidines as potential antitumor and radioprotective agents.
    Ghorab MM; Ragab FA; Noaman E; Heiba HI; Galal M
    Arzneimittelforschung; 2006; 56(7):553-60. PubMed ID: 16927539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toyocamycin: phosphorylation and incorporation into RNA and DNA and the biochemical properties of the triphosphate.
    Suhadolnik RJ; Uematsu T; Uematsu H
    Biochim Biophys Acta; 1967 Nov; 149(1):41-9. PubMed ID: 5582755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.